# Quality Score Report: ADR-001 Test Harness Architecture (Phase 8 Gate A)

## Document Sections

| Section | Purpose |
|---------|---------|
| [L0 Executive Summary](#l0-executive-summary) | Score, verdict, and one-line assessment |
| [Scoring Context](#scoring-context) | Deliverable metadata and strategy reference |
| [Score Summary](#score-summary) | Weighted composite and threshold comparison |
| [Dimension Scores](#dimension-scores) | Per-dimension table with evidence summary |
| [Detailed Dimension Analysis](#detailed-dimension-analysis) | Full per-dimension evidence, gaps, and improvement path |
| [Improvement Recommendations](#improvement-recommendations) | Priority-ordered revision directives |
| [Leniency Bias Check](#leniency-bias-check) | Anti-leniency protocol confirmation |

---

## L0 Executive Summary

**Score:** 0.919/1.00 | **Verdict:** REVISE | **Weakest Dimension:** Internal Consistency (0.88)

**One-line assessment:** ADR-001 is a near-threshold, high-quality architecture decision record that falls 0.001 below the 0.92 gate due to a documented-but-unresolved score discrepancy between the ADR comparison matrix (4.45) and the Phase 5 trade study score (4.65) cited in the L0 summary, and a gap in explicit justification for the 6-dimension weights used in the options evaluation.

---

## Scoring Context

| Field | Value |
|-------|-------|
| **Deliverable** | `projects/PROJ-035-skill-optimization/decisions/ADR-001-test-harness-architecture.md` |
| **Deliverable Type** | ADR |
| **Criticality Level** | C3 (significant: architecture decision, >10 files impacted, >1 day to reverse) |
| **Scoring Strategy** | S-014 (LLM-as-Judge) |
| **SSOT Reference** | `.context/rules/quality-enforcement.md` |
| **Strategy Findings Incorporated** | No |
| **Scored** | 2026-03-06T00:00:00Z |

---

## Score Summary

| Metric | Value |
|--------|-------|
| **Weighted Composite** | 0.919 |
| **Threshold** | 0.92 (H-13) |
| **Verdict** | REVISE |
| **Strategy Findings Incorporated** | No |

---

## Dimension Scores

| Dimension | Weight | Score | Weighted | Evidence Summary |
|-----------|--------|-------|----------|-----------------|
| Completeness | 0.20 | 0.96 | 0.192 | All Nygard sections present; 3 options fully scored across 6 dimensions; L0/L1/L2 complete; PROJ-017 relationship dedicated section; 21-entry evidence table; navigation table; self-review checklist |
| Internal Consistency | 0.20 | 0.88 | 0.176 | Option scores align with rejection rationale; L0/L1 match at level of conclusion; minor unresolved discrepancy: ADR matrix shows Option B at 4.45 while L0 cites Phase 5 score of 4.65, with a 0.50 vs. 0.80 point lead gap -- acknowledged in a footnote but the footnote requires careful reading to reconcile |
| Methodological Rigor | 0.20 | 0.89 | 0.178 | Kepner-Tregoe weighted evaluation applied; steelman (S-003) applied to all three options per H-16; sensitivity analysis present; FMEA methodology for risks; evidence tracing from 6 prior phases; dimension weights stated but not individually justified within the ADR |
| Evidence Quality | 0.15 | 0.93 | 0.140 | 21 structured evidence entries with artifact paths and specific section locations; direct quotations from ICML 2025, ASE 2025, Science 2023; every significant architectural claim has an inline source tag; no ungrounded assertions found |
| Actionability | 0.15 | 0.93 | 0.140 | Concrete 6-phase implementation roadmap; code examples for all integration patterns; tiered evaluation modes with cost estimates; FMEA mitigations phase-assigned; decision review triggers defined; effort estimates acknowledged as qualitative (honest but limits planning-grade use) |
| Traceability | 0.10 | 0.94 | 0.094 | Dedicated Evidence Traceability section with 21 entries; every option dimension score has inline source citation; forces table maps to evidence; decision rationale references 5 specific prior artifacts; constraint sources identified |
| **TOTAL** | **1.00** | | **0.919** | |

---

## Detailed Dimension Analysis

### Completeness (0.96/1.00)

**Evidence:**

The ADR satisfies every Nygard ADR section: Status, Context, Decision, Consequences, plus L0 Executive Summary, L1 technical sections (7 subsections: Context, Options, Decision, Technical Implementation, Consequences, Risks, Implementation Roadmap, PROJ-017 Relationship), and L2 Architectural Implications. The Document Sections navigation table (H-23) is present with anchor links.

Three options are evaluated. Each option receives: a Description, a Steelman (S-003 applied to all three per H-16), an Evaluation table scoring all 6 dimensions with cited rationale, and either a "Why Not Selected" section (Options A and C) or implicit selection via the Decision section (Option B).

The PROJ-017 ADR-002 relationship receives a dedicated section with a comparison table distinguishing question types, a shared infrastructure inventory, divergence points, and a concrete sequencing recommendation.

The 21-entry evidence traceability table covers every major claim. The self-review checklist at the end explicitly verifies all major structural requirements.

**Gaps:**

No material completeness gaps identified. The one minor item is that the sixth option evaluation dimension (Time to First Value) is not present in the Constraints section, which documents Phase 5's mandatory criteria but does not explicitly connect M-001/M-002/M-003/M-004 to the evaluation dimensions used in the ADR comparison matrix.

**Improvement Path:**

This dimension is at 0.96 -- approaching ceiling. The only path to 1.00 would require adding explicit traceability from the Phase 5 mandatory criteria (M-001 through M-004) to the six evaluation dimensions used in the ADR matrix.

---

### Internal Consistency (0.88/1.00)

**Evidence:**

Option scores are internally consistent with their rejection rationale. Option A is rejected because Statistical Rigor = 1/5 and Determinism Coverage = 2/5; both scores appear consistently in the evaluation table and are cited in "Why Not Selected." Option C is rejected because Time to First Value = 1/5 and Integration Feasibility = 2/5; both are consistent with the rejection rationale.

The L0 summary conclusion ("Four-Layer Composite scored highest by a structural margin") matches the L1 comparison matrix, where Option B leads Option C by 0.50 points and Option A by 1.05 points.

**Gaps:**

There is a documented-but-imperfectly-resolved numeric discrepancy:

- L0 (line 61): "Phase 5 Kepner-Tregoe weighted evaluation, the Four-Layer Composite scored 4.65/5.00, leading the next-best alternative (Statistical-Only at 3.85) by 0.80 points."
- ADR comparison matrix (lines 219-235): Option B total = 4.45, Option C total = 3.95, Option A = 3.40. The gap from Option B to Option C is 0.50 points, not 0.80.

The footnote at line 237-239 acknowledges this: "This ADR uses a six-dimension evaluation (adding Time to First Value)... whereas Phase 5 used a six-dimension evaluation with Evidence Basis instead of Time to First Value, and different dimension weights." This explanation is technically correct -- two different matrices with different configurations produce different scores.

The problem is that the L0 Summary cites the Phase 5 score (4.65, 0.80 lead) as the primary evidence for "scored highest by a structural margin," while the ADR's own matrix produces a different score (4.45, 0.50 lead). A reader who reads the L0 summary and then checks the ADR matrix will find numbers that do not match, requiring them to locate and parse the footnote to understand why. This is a minor but genuine consistency issue for the executive-facing L0 section.

**Improvement Path:**

Revise the L0 summary to cite the ADR's own matrix score (4.45) rather than the Phase 5 score (4.65), or add a parenthetical in the L0 that explicitly flags "ADR evaluation matrix: 4.45; Phase 5 matrix with different weight configuration: 4.65 -- see Options Comparison Matrix note." This brings L0 into alignment with L1 without removing the Phase 5 citation. Estimated effort: 2-3 sentences.

---

### Methodological Rigor (0.89/1.00)

**Evidence:**

The options evaluation uses a Kepner-Tregoe weighted scoring approach with 6 dimensions and a sensitivity analysis that tests whether the recommendation is robust to weight changes. The steelman technique (S-003) is applied to all three options per H-16, with each steelman identifying the genuine strongest case for each option -- not a strawman.

Options are derived from Phase 5 analysis rather than predetermined. The self-review checklist at line 629 explicitly states: "Options derived from Phase 5 analysis: Phase 5 identified Five-Layer Composite as top-scoring; 3 ADR options represent simpler/recommended/comprehensive alternatives from Phase 5 evidence."

The FMEA methodology is applied to the risk register with structured RPN calculation (Severity × Occurrence × Detection) and phase-assigned mitigations.

Evidence tracing covers six prior phases (1A, 1B, 1C, 1D, 3, 5) with specific section citations.

**Gaps:**

The six evaluation dimensions and their weights (Refactoring Safety 0.25, Migration Confidence 0.15, Determinism Coverage 0.10, Statistical Rigor 0.20, Integration Feasibility 0.15, Time to First Value 0.15) are stated in the comparison matrix but not individually justified within the ADR. The reader must trust that the weights are well-founded based on Phase 5 citations, but the ADR does not explain why, for example, Refactoring Safety should receive 0.25 weight versus Statistical Rigor at 0.20, or why Time to First Value warrants inclusion as a full dimension alongside core technical criteria.

This is a moderate gap: dimension weights have a direct bearing on the outcome, and the sensitivity analysis (line 239) only partially addresses it by showing that the recommendation is robust to one specific weight perturbation (doubling Time to First Value at the expense of Statistical Rigor).

**Improvement Path:**

Add a "Weight Justification" subsection within the Options Evaluated section that provides a one-sentence rationale for each dimension's weight, anchored to the problem statement. For example: "Refactoring Safety (0.25, highest weight) -- the primary use case is regression detection during prompt editing; this dimension directly measures how well each option serves that use case." Two to four sentences per dimension would close this gap.

---

### Evidence Quality (0.93/1.00)

**Evidence:**

The Evidence Traceability section provides 21 entries in a structured four-column table (Evidence ID, Source Artifact, Specific Location, Claim Supported). Every major architectural claim has an inline citation using either [Phase N Section] format or [Evidence ID] referencing the traceability table.

Direct research citations with specificity include:
- ICML 2025: "CLT-based methods perform very poorly" (cited in Force F-2, Option A rejection, Phase 1D Innovation #6)
- LLMORPH ASE 2025: "560,000 tests, 8.6% false positive rate" (cited in Layer 3 evidence)
- PPI: "published in Science (2023) and extended at NeurIPS 2024" (cited in Option C evaluation)
- DeepEval: "80-87% human correlation with debiasing" (cited in Force F-5)

No ungrounded assertions were found. Claims about component capabilities (promptfoo "100+ provider integrations," DeepEval "14+ pytest-compatible evaluation metrics") have evidence IDs linking to Phase 1B research.

**Gaps:**

The evidence quality is high. One minor limitation: the Phase 1/3/5 source artifacts are referenced by path within the PROJ-035 work directory, but those paths cannot be independently verified within this ADR -- they are assumed to exist and contain the stated content. This is an inherent limitation of a multi-phase pipeline ADR, not a deficiency in the ADR itself. No score reduction applied for this structural reality.

A secondary minor gap: the GitHub star counts for promptfoo (10.8K) and DeepEval (14K+) are cited as evidence of community support and evidence basis, but no date of observation is provided for these figures. Star counts change over time and may be stale.

**Improvement Path:**

Add observation dates to GitHub star count citations (e.g., "10.8K stars as of 2026-03-06"). This is a minor evidence quality improvement.

---

### Actionability (0.93/1.00)

**Evidence:**

The implementation roadmap specifies 6 phases with concrete deliverables, FMEA failure modes addressed per phase, effort estimates, and value-delivered descriptions. The minimum viable milestone is explicitly defined: "Phases A+B deliver a working, statistically valid regression harness in approximately 2-3 weeks."

Code patterns are provided for all three integration boundaries:
- Layer 2/3 integration: `ParaphraseConsistencyMetric` class with method signatures
- Layer 2/4 integration: `compare_versions` function with types and return classification
- Test case definition: YAML format with assertion types

File paths are specified: `tests/prompt-regression/`, `tests/prompt-regression/*.yaml`, `jerry/testing/stats.py`. The tiered evaluation modes define concrete run counts (Smoke=1, Standard=10, Full=30) and cost estimates ($0, ~$2, ~$5-8).

Decision review triggers are concrete and tied to external events (promptfoo adding native regression comparison, Anthropic releasing evaluation tooling, Jerry reaching 100+ agents).

**Gaps:**

Effort estimates are explicitly labeled as qualitative at line 493-494: "Effort estimates are qualitative, derived from component complexity and integration documentation maturity... should be treated as directional guidance rather than planning-grade estimates until a prototype sprint validates them." This is honest, but it means the roadmap cannot be directly used for sprint planning or commitment without further decomposition.

The risk mitigations in the FMEA table are phase-assigned but not decomposed into specific implementation steps. For example, FM-001 mitigation is "Position randomization + rubric shuffling as mandatory harness configuration" but the ADR does not specify where in the codebase this configuration lives, what the configuration schema looks like, or how it is enforced.

**Improvement Path:**

For the highest-priority FMEA risks (FM-007, FM-001, FM-003), add one to two sentences in the mitigation column specifying the implementation location and configuration schema. This closes the gap between "mitigation identified" and "mitigation implementable."

---

### Traceability (0.94/1.00)

**Evidence:**

The dedicated Evidence Traceability section with 21 entries provides full traceability from claims to source artifacts. Every option dimension score has an inline citation (e.g., "Score 3: Phase 5 D1: promptfoo-Only=3, DeepEval-Only=3"). Every force in the Forces table cites an evidence source and identifies the decision impact.

The Decision Rationale Summary (5 numbered points) each cite a specific artifact and section (e.g., "[Phase 5 L1 Comparative Matrix]", "[Phase 3 L1.5]", "[Phase 1C L2 Gaps 1-5]").

The PROJ-017 relationship section traces the shared infrastructure claim to "[Phase 5 L2: 'No duplicate infrastructure']" and "[Phase 5 L2: 'A shared Python statistical module serves both projects without duplication']".

**Gaps:**

The traceability chain from the ADR's dimension weights back to a source is not fully established. The comparison matrix uses weights (0.25, 0.15, 0.10, 0.20, 0.15, 0.15) without a traceability entry connecting those specific weights to a Phase 5 artifact. This overlaps with the Methodological Rigor gap.

**Improvement Path:**

Add evidence entry E-022 for the dimension weight selection, citing the Phase 5 artifact and section where those weights were established or derived.

---

## Improvement Recommendations (Priority Ordered)

| Priority | Dimension | Current | Target | Recommendation |
|----------|-----------|---------|--------|----------------|
| 1 | Internal Consistency | 0.88 | 0.92 | Revise the L0 summary to cite the ADR's own comparison matrix score (4.45) rather than the Phase 5 score (4.65). Add a parenthetical or footnote in L0 that reads: "ADR six-dimension matrix: 4.45/5.00, leading Option C by 0.50; Phase 5 evaluation with different weight configuration: 4.65/5.00." This aligns L0 with L1 without removing the Phase 5 citation. Estimated: 2-3 sentences. |
| 2 | Methodological Rigor | 0.89 | 0.92 | Add a "Weight Justification" sub-table in the Options Evaluated section providing a one-sentence rationale for each evaluation dimension's weight. Anchor each rationale to the problem statement (e.g., "Refactoring Safety: 0.25 -- primary use case of the harness"). Also add evidence entry E-022 citing the Phase 5 source for the weight values. |
| 3 | Actionability | 0.93 | 0.95 | For FM-007, FM-001, FM-003 (top three FMEA risks by RPN), expand the mitigation column to specify the implementation location and configuration schema. Two sentences per risk is sufficient. |
| 4 | Evidence Quality | 0.93 | 0.95 | Add observation dates to GitHub star count citations for promptfoo and DeepEval (one-line change per citation). |

---

## Leniency Bias Check

- [x] Each dimension scored independently before computing weighted composite
- [x] Evidence documented for each score with specific quotes and section references
- [x] Uncertain scores resolved downward: Internal Consistency was uncertain between 0.88 and 0.90; resolved to 0.88. Methodological Rigor was uncertain between 0.89 and 0.91; resolved to 0.89.
- [x] First-draft calibration considered: this is a Phase 7 output (not a first draft), following 6 prior phases of evidence accumulation. Higher baseline appropriate, but 0.92+ threshold still applies and is actively enforced.
- [x] No dimension scored above 0.95 without exceptional evidence (Evidence Quality and Traceability at 0.93-0.94 reflect genuine near-excellence with documented minor gaps)
- [x] Composite verified mathematically: (0.96 × 0.20) + (0.88 × 0.20) + (0.89 × 0.20) + (0.93 × 0.15) + (0.93 × 0.15) + (0.94 × 0.10) = 0.192 + 0.176 + 0.178 + 0.1395 + 0.1395 + 0.094 = 0.919

---

## Verdict

**REVISE** -- Score 0.919 falls 0.001 below the 0.92 threshold (H-13).

The ADR is substantively strong -- the evidence quality, actionability, and traceability dimensions all exceed 0.92. The two dimensions pulling the composite below threshold (Internal Consistency at 0.88, Methodological Rigor at 0.89) have targeted, low-effort remediation paths. Specifically:

1. The L0 summary must align its cited score and margin with the ADR's own comparison matrix (Priority 1, estimated 2-3 sentences).
2. Dimension weights require individual justification within the ADR (Priority 2, estimated one table with 6 rows).

Both fixes are additive (no content removal required) and do not alter the decision or recommendation. After revision, the composite is expected to reach 0.93-0.94.

---

*Score report produced: 2026-03-06*
*Agent: adv-scorer (Phase 8 Gate A, PROJ-035 FEAT-035-001)*
*Deliverable: ADR-001-test-harness-architecture.md*
*Strategy: S-014 LLM-as-Judge, 6-dimension SSOT weighted composite*
